Precision BioLogic Wins FDA Approval
Precision BioLogic, a Dartmouth medtech company that sells diagnostic testing supplies, has received United States Food and Drug Administration approval for its product for the bleeding disorder Hemophilia B.
The Hemophilia test, also recently approved by Health Canada, is being released in response to increasing market demand for chromogenic assays and is the only Hemophilia B test of its kind